Population-based studies on ovarian cancer providing survival estimates by age, histology, laterality, and stage have been sparse. We aimed to derive the most up-to-date and detailed survival ...

Health-related quality of life (HRQoL) results from the AURELIA trial evaluating bevacizumab (BEV) plus chemotherapy (CT) for platinum-resistant recurrent ovarian cancer (OC). Efficacy and safety of ...

Over the past 10 to 15 years, we have observed convergence of several forces that have stimulated enhanced interest in rare ovarian cancers and have allowed us to begin the process of unmasking tumor ...

The association between residual tumor volume after primary cytoreduction and survival was less consistent in patients with low-grade serous ovarian carcinoma (LGSOC) compared with other histology ...

—The more aggressive the cancer, the more likely it is that lifestyle factors like tobacco use may be associated with advanced disease. Reviewed by Vrunda Bhavsar Desai, MD, FACOG, Adjunct Professor ...